Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Yazed, AlRuthia"'
Autor:
Yazed AlRuthia
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 10, Pp 102164- (2024)
Background: The utilization rate of antipsychotics to treat different mental disorders is rising. However, little is known about their side effects’ impact on depression levels. Therefore, the objective of this study was to examine the association
Externí odkaz:
https://doaj.org/article/9cde9c4711ac45b7a2692d86b139b12a
Autor:
Ayla M. Tourkmani, Turki J. Alharbi, Abdulaziz M. Bin Rsheed, Azzam F. Alotaibi, Mohammed AlEisaa, Ibrahim M. Youzghadli, Yazed AlRuthia, Alian A. Alrasheedy
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Objective Prediabetes is prevalent in Saudi Arabia and globally. It is associated with adverse health outcomes and complications. Consequently, this study aimed to determine the risk factors associated with developing prediabetes in Saudi Arabia.Meth
Externí odkaz:
https://doaj.org/article/938e7c7fb93945dd91735dfb5fc18bb5
Autor:
Areej S. Albahdal, Amjad M. Alotaibi, Miteb A. Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background The study aimed to examine the direct medical cost and impact of tocilizumab (TOZ) versus adalimumab (ADM) and etanercept (ETC) on reducing the levels of two inflammatory markers (e.g., C-reactive protein (CRP) and erythrocyte sed
Externí odkaz:
https://doaj.org/article/c18466bafb4b4e77b3c39bbbd050098f
Autor:
Yazed AlRuthia, Almaha H. Alfakhri, Ibtisam Alharbi, Fadi Ali Alghamdi, Miteb A. Alanazi, Abdullah Abdulrahman Alrabiah, Anwar Abdulrazzag Alsouan, Abdulrahman Abdullah Alshaikh, Majed Ali Almasaoud
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Psoriasis, an immune-mediated chronic inflammatory disease primarily affecting skin and joints, has varying prevalence rates globally. It manifests in five types, with chronic plaque psoriasis being the most common. Treatment, whi
Externí odkaz:
https://doaj.org/article/8e2a791e021e4fb18449642b6e8c18db
Autor:
Ibrahim Sales, Yazed AlRuthia
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102053- (2024)
Background: Adherence to prescription medications is vital to the success of any treatment plan, especially for chronic health conditions, such as hypertension (HTN). Although there are different scales used in assessing adherence to prescription med
Externí odkaz:
https://doaj.org/article/29bbb1fc228b42eca150778bab187b0d
Autor:
Yazed AlRuthia, Khaled Hani Aburisheh, Sondus Ata, Raghad Bin Salleeh, Shahad B. Alqudhibi, Raghad B. Alqudhibi, Ziad Alkraidis, Hala Humood Alkhalaf, Abdulrahman Abdullah Almogirah, Muhammad Mujammami, Reem Al Khalifah
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102057- (2024)
Introduction: Semaglutide, a Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA), is often prescribed for managing type 2 diabetes, particularly in cases unresponsive to other hypoglycemic agents. Despite its popularity, the real-world efficacy and c
Externí odkaz:
https://doaj.org/article/c93a2c7825d641a49e8780e0cd56625e
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Vol 6, Iss 4, Pp 127-136 (2023)
Introduction There is an increased interest in cost consciousness concerning healthcare spending worldwide. In the Arab world, a major transformation is underway in the healthcare sectors to achieve national and government visions to attain better ou
Externí odkaz:
https://doaj.org/article/0c6d985f5e384a7e87bec7367214099f
Autor:
Yazed AlRuthia, Nouf Mohammed Almutiri, Raghdah Musa Almutairi, Omar Almohammed, Hani Alhamdan, Sobhi Ali El-Haddad, Yousif Abdu Asiri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 6, Pp 948-954 (2023)
Background: The global supply chains of essential medicines faced frequent disruptions over the past five years, particularly during the COVID-19 pandemic. Different causes of prescription drug supply interruptions have been identified in Saudi Arabi
Externí odkaz:
https://doaj.org/article/076aadb268594c5e96d4ff29288d2d82
Autor:
Khloud Mubark Alotaibi, Mohannad Alsuhaibani, Khalid S. Al-Essa, Ahmed Khamis Bamaga, Amnah S. Mukhtar, Ali Mohammed Alrumaih, Huda F. Al-Hasinah, Shaikhah Aldossary, Fouad Alghamdi, Mohamad-Hani Temsah, Norah Abanmy, Monira Alwhaibi, Yousif Asiri, Yazed AlRuthia
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundSpinal muscular atrophy (SMA) is a rare debilitating condition with a significant burden for patients and society. However, little is known about how it affects Saudi Arabia's population. The socioeconomic and medical characteristics of aff
Externí odkaz:
https://doaj.org/article/93269d5213e04f6f935a604668566766
Autor:
Amjad M. Alotaibi, Areej S. Albahdal, Norah Abanmy, Monira Alwhaibi, Yousif Asiri, Yazed AlRuthia
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Purpose: The aim of this study was to assess the quality of life (QOL) of patients with rheumatoid arthritis (RA) on tocilizumab versus other commonly used monoclonal antibodies (mAbs) (e.g., adalimumab and etanercept).Methods: This was an interview-
Externí odkaz:
https://doaj.org/article/6fa15cd128074e9790335a56deaeac84